12th Pre-Filled Syringes, Wearable & Autoinjector Drug Delivery

About the 12th Pre-Filled Syringes, Wearable & Autoinjector Drug Delivery I #Epfs by Etapa Pharma

As we approach the 12th Pre-Filled Syringes, Wearable & Autoinjector Drug Delivery Summit (#Epfs2026), March 11–12, 2026 in Munich, Germany, here are the key trends, challenges, and future perspectives shaping the field:

Current Trends

• Smart & Connected Devices – Advances in digital health integration and smart pre-filled syringes are improving real-time monitoring, adherence, and patient engagement.
• Sustainability & Eco-Design – Growing demand for recyclable materials, greener manufacturing, and life-cycle assessments is reshaping device development.

Key Challenges

• Regulatory Compliance – Adapting to evolving global standards for combination products and parenteral systems, with stronger requirements for safety and efficacy data.
• Supply Chain Resilience – Mitigating disruptions in raw materials, components, and global logistics to ensure uninterrupted manufacturing.

Future Perspectives

• Personalized & Advanced Therapies – Pre-filled syringes are evolving to meet the needs of biologics, gene therapies, and patient-specific treatments.

  ---

• Automation & Next-Gen Manufacturing – Robotics, digital twins, and advanced analytics are driving efficiency, scalability, and quality control.

Current Developments

• Research & Formulation Breakthroughs – Innovations in device design and formulation science are enabling safer, more effective delivery systems.
• Market Dynamics – Competitive landscapes are shifting as new players enter and established leaders adapt to patient-centric, tech-driven demands.

Join leading experts in pharma, medtech, and combination products to explore these opportunities and challenges, and shape the next generation of drug delivery systems at #Epfs 2026.